Perfil
Stefan Proniuk worked as a Scientist at CIMA Labs, Inc. from 2000 to 2002.
He then worked as a Senior Manager-Pharmaceutical Technologies at Neurocrine Biosciences, Inc. from 2002 to 2008.
From 2008 to 2017, he served as the Chief Development Officer at Arno Therapeutics, Inc. Dr. Proniuk holds an MBA from San Diego State University and a doctorate from the University of Arizona.
Antiguos cargos conocidos de Stefan Proniuk.
| Empresas | Cargo | Fin |
|---|---|---|
| ARNO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/04/2017 |
| NEUROCRINE BIOSCIENCES, INC. | Corporate Officer/Principal | 01/01/2008 |
CIMA Labs, Inc.
CIMA Labs, Inc. Pharmaceuticals: OtherHealth Technology Develops and manufactures pharmaceutical products | Corporate Officer/Principal | 01/01/2002 |
Formación de Stefan Proniuk.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
CIMA Labs, Inc.
CIMA Labs, Inc. Pharmaceuticals: OtherHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
San Diego State University
San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Arizona
University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arno Therapeutics, Inc.
Arno Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the clinical development of targeted cancer therapies and novel drug candidates for unmet medical needs | Health Technology |
- Bolsa de valores
- Insiders
- Stefan Proniuk
















